Literature DB >> 9533519

Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.

D H Lee1, S C Yang, S J Hong, B H Chung, I Y Kim.   

Abstract

Telomerase is an enzyme that immortalizes cells by maintaining a constant telomere length. Here, telomerase activity in bladder washes was analyzed and compared with the final pathological diagnosis in 23 patients with bladder transitional cell carcinoma (TCC). Bladder washes and normal tissues were obtained from each patient prior to transurethral resection of bladder tumor. Telomerase activity was detected using telomeric repeat amplification protocol assay based on PCR. Cytological diagnosis of centrifuged cells from bladder washes was made using Papanicolau's stain. Results demonstrated that telomerase activity was detected in 95.7% of both cancer tissues and bladder washes. In normal tissues, telomerase activity was not detected in 22 of 23 samples. Regarding cytological diagnosis, only 69.6% of bladder wash samples had positive cytology. Moreover, in five cases of grade 1 TCC, only 20% of the cytological specimens were positive for malignancy, whereas 80% showed positive telomerase activity. These results demonstrate that telomerase activity is detectable in a majority of human bladder cancer tissues and bladder washes obtained from patients with TCC. In addition, results of this study suggest that the presence of telomerase in bladder washes may be a specific marker of bladder cancer, especially in low-grade tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9533519

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  8 in total

1.  Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.

Authors:  R Fedriga; R Gunelli; O Nanni; F Bacci; D Amadori; D Calistri
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

2.  Critical evaluation of urinary markers for bladder cancer detection and monitoring.

Authors:  Shahrokh F Shariat; Jose A Karam; Yair Lotan; Pierre I Karakiewizc
Journal:  Rev Urol       Date:  2008

3.  Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer.

Authors:  Letizia Mezzasoma; Cinzia Antognelli; Chiara Del Buono; Fabrizio Stracci; Emanuele Cottini; Giovanni Cochetti; Vincenzo N Talesa; Ettore Mearini
Journal:  BMC Urol       Date:  2010-10-04       Impact factor: 2.264

4.  Urine telomerase: an important marker in the diagnosis of bladder cancer.

Authors:  Maria Aurora Sanchini; Sara Bravaccini; Laura Medri; Roberta Gunelli; Oriana Nanni; Franco Monti; Paolo Carlo Baccarani; Alberto Ravaioli; Eduard Bercovich; Dino Amadori; Daniele Calistri
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

5.  Telomerase activity in bladder cancer tissue.

Authors:  Akihiro Morii; Akira Komiya; Akiou Okumura; Hideki Fuse
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

6.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

7.  Jun dimerization protein 2 controls hypoxia-induced replicative senescence via both the p16Ink4a-pRb and Arf-p53 pathways.

Authors:  Koji Nakade; Chang-Shen Lin; Xiao-Yu Chen; Ming-Ho Tsai; Kenly Wuputra; Zhi-Wei Zhu; Jian-Zhi Pan; Kazunari K Yokoyama
Journal:  FEBS Open Bio       Date:  2017-10-16       Impact factor: 2.693

8.  Diagnostic Value of Telomerase Activity in Patients With Bladder Cancer: A Meta-Analysis of Diagnostic Test.

Authors:  Lei Peng; Jinze Li; Chunyang Meng; Jinming Li; Dandan Tang; Fangxue Guan; Peng Xu; Tangqiang Wei; Yunxiang Li
Journal:  Front Oncol       Date:  2020-12-03       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.